Literature DB >> 24951032

Lumbar spine texture enhances 10-year fracture probability assessment.

W D Leslie1, H Johansson, J A Kanis, O Lamy, A Oden, E V McCloskey, D Hans.   

Abstract

UNLABELLED: We found that lumbar spine texture analysis using trabecular bone score (TBS) is a risk factor for MOF and a risk factor for death in a retrospective cohort study from a large clinical registry for the province of Manitoba, Canada.
INTRODUCTION: FRAX® estimates the 10-year probability of major osteoporotic fracture (MOF) using clinical risk factors and femoral neck bone mineral density (BMD). Trabecular bone score (TBS), derived from texture in the spine dual X-ray absorptiometry (DXA) image, is related to bone microarchitecture and fracture risk independently of BMD. Our objective was to determine whether TBS provides information on MOF probability beyond that provided by the FRAX variables.
METHODS: We included 33,352 women aged 40-100 years (mean 63 years) with baseline DXA measurements of lumbar spine TBS and femoral neck BMD. The association between TBS, the FRAX variables, and the risk of MOF or death was examined using an extension of the Poisson regression model.
RESULTS: During the mean of 4.7 years, 1,754 women died and 1,872 sustained one or more MOF. For each standard deviation reduction in TBS, there was a 36 % increase in MOF risk (HR 1.36, 95 % CI 1.30-1.42, p < 0.001) and a 32 % increase in death (HR 1.32, 95 % CI 1.26-1.39, p < 0.001). When adjusted for significant clinical risk factors and femoral neck BMD, lumbar spine TBS was still a significant predictor of MOF (HR 1.18, 95 % CI 1.12-1.23) and death (HR 1.20, 95 % CI 1.14-1.26). Models for estimating MOF probability, accounting for competing mortality, showed that low TBS (10th percentile) increased risk by 1.5-1.6-fold compared with high TBS (90th percentile) across a broad range of ages and femoral neck T-scores.
CONCLUSIONS: Lumbar spine TBS is able to predict incident MOF independent of FRAX clinical risk factors and femoral neck BMD even after accounting for the increased death hazard.

Entities:  

Mesh:

Year:  2014        PMID: 24951032     DOI: 10.1007/s00198-014-2761-y

Source DB:  PubMed          Journal:  Osteoporos Int        ISSN: 0937-941X            Impact factor:   4.507


  28 in total

Review 1.  FRAX and its applications to clinical practice.

Authors:  John A Kanis; Anders Oden; Helena Johansson; Fredrik Borgström; Oskar Ström; Eugene McCloskey
Journal:  Bone       Date:  2009-02-03       Impact factor: 4.398

2.  Bone microarchitecture assessed by TBS predicts osteoporotic fractures independent of bone density: the Manitoba study.

Authors:  Didier Hans; Andrew L Goertzen; Marc-Antoine Krieg; William D Leslie
Journal:  J Bone Miner Res       Date:  2011-11       Impact factor: 6.741

Review 3.  Pathophysiology of osteoporosis: new mechanistic insights.

Authors:  Laura A G Armas; Robert R Recker
Journal:  Endocrinol Metab Clin North Am       Date:  2012-06-09       Impact factor: 4.741

Review 4.  Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. Report of a WHO Study Group.

Authors: 
Journal:  World Health Organ Tech Rep Ser       Date:  1994

Review 5.  Trabecular bone score (TBS): available knowledge, clinical relevance, and future prospects.

Authors:  V Bousson; C Bergot; B Sutter; P Levitz; B Cortet
Journal:  Osteoporos Int       Date:  2011-11-15       Impact factor: 4.507

Review 6.  Quality of life in patients with osteoporosis.

Authors:  Paul Lips; Natasja M van Schoor
Journal:  Osteoporos Int       Date:  2004-12-18       Impact factor: 4.507

7.  Independent clinical validation of a Canadian FRAX tool: fracture prediction and model calibration.

Authors:  William D Leslie; Lisa M Lix; Helena Johansson; Anders Oden; Eugene McCloskey; John A Kanis
Journal:  J Bone Miner Res       Date:  2010-11       Impact factor: 6.741

8.  BMD at multiple sites and risk of fracture of multiple types: long-term results from the Study of Osteoporotic Fractures.

Authors:  Katie L Stone; Dana G Seeley; Li-Yung Lui; Jane A Cauley; Kristine Ensrud; Warren S Browner; Michael C Nevitt; Steven R Cummings
Journal:  J Bone Miner Res       Date:  2003-11       Impact factor: 6.741

9.  Construction and validation of a population-based bone densitometry database.

Authors:  William D Leslie; Patricia A Caetano; Leonard R Macwilliam; Gregory S Finlayson
Journal:  J Clin Densitom       Date:  2005       Impact factor: 2.963

10.  Osteoporosis-related fracture case definitions for population-based administrative data.

Authors:  Lisa M Lix; Mahmoud Azimaee; Beliz Acan Osman; Patricia Caetano; Suzanne Morin; Colleen Metge; David Goltzman; Nancy Kreiger; Jerilynn Prior; William D Leslie
Journal:  BMC Public Health       Date:  2012-05-18       Impact factor: 3.295

View more
  35 in total

1.  Clinical performance of an updated trabecular bone score (TBS) algorithm in men and women: the Manitoba BMD cohort.

Authors:  G I Schacter; W D Leslie; S R Majumdar; S N Morin; L M Lix; D Hans
Journal:  Osteoporos Int       Date:  2017-07-21       Impact factor: 4.507

2.  Association between bone indices assessed by DXA, HR-pQCT and QCT scans in post-menopausal women.

Authors:  Anne Kristine Amstrup; Niels Frederik Breum Jakobsen; Emil Moser; Tanja Sikjaer; Leif Mosekilde; Lars Rejnmark
Journal:  J Bone Miner Metab       Date:  2015-08-21       Impact factor: 2.626

3.  Spine Trabecular Bone Score as an Indicator of Bone Microarchitecture at the Peripheral Skeleton in Kidney Transplant Recipients.

Authors:  Matthew Luckman; Didier Hans; Natalia Cortez; Kyle K Nishiyama; Sanchita Agarawal; Chengchen Zhang; Lucas Nikkel; Sapna Iyer; Maria Fusaro; Edward X Guo; Donald J McMahon; Elizabeth Shane; Thomas L Nickolas
Journal:  Clin J Am Soc Nephrol       Date:  2017-03-27       Impact factor: 8.237

4.  Effects of Teriparatide, Denosumab, or Both on Spine Trabecular Microarchitecture in DATA-Switch: a Randomized Controlled Trial.

Authors:  Joy N Tsai; Linda A Jiang; Hang Lee; Didier Hans; Benjamin Z Leder
Journal:  J Clin Densitom       Date:  2017-06-16       Impact factor: 2.617

5.  Trabecular bone score may improve FRAX® prediction accuracy for major osteoporotic fractures in elderly Japanese men: the Fujiwara-kyo Osteoporosis Risk in Men (FORMEN) Cohort Study.

Authors:  M Iki; Y Fujita; J Tamaki; K Kouda; A Yura; Y Sato; J-S Moon; R Winzenrieth; N Okamoto; N Kurumatani
Journal:  Osteoporos Int       Date:  2015-03-10       Impact factor: 4.507

6.  Prediction of major osteoporotic and hip fractures in Australian men using FRAX scores adjusted with trabecular bone score.

Authors:  K L Holloway; M Mohebbi; A G Betson; D Hans; N K Hyde; S L Brennan-Olsen; M A Kotowicz; J A Pasco
Journal:  Osteoporos Int       Date:  2017-09-23       Impact factor: 4.507

7.  Trabecular Bone Score and Incident Fragility Fracture Risk in Adults with Reduced Kidney Function.

Authors:  Kyla L Naylor; Jerilynn Prior; Amit X Garg; Claudie Berger; Lisa Langsetmo; Jonathan D Adachi; David Goltzman; Christopher S Kovacs; Robert G Josse; William D Leslie
Journal:  Clin J Am Soc Nephrol       Date:  2016-10-24       Impact factor: 8.237

8.  The added value of trabecular bone score to FRAX® to predict major osteoporotic fractures for clinical use in Chinese older people: the Mr. OS and Ms. OS cohort study in Hong Kong.

Authors:  Y Su; J Leung; D Hans; O Lamy; T Kwok
Journal:  Osteoporos Int       Date:  2016-08-26       Impact factor: 4.507

Review 9.  A systematic review of intervention thresholds based on FRAX : A report prepared for the National Osteoporosis Guideline Group and the International Osteoporosis Foundation.

Authors:  John A Kanis; Nicholas C Harvey; Cyrus Cooper; Helena Johansson; Anders Odén; Eugene V McCloskey
Journal:  Arch Osteoporos       Date:  2016-07-27       Impact factor: 2.617

10.  Trabecular Bone Score in Obese and Nonobese Subjects With Primary Hyperparathyroidism Before and After Parathyroidectomy.

Authors:  Yu-Kwang Donovan Tay; Natalie E Cusano; Mishaela R Rubin; John Williams; Beatriz Omeragic; John P Bilezikian
Journal:  J Clin Endocrinol Metab       Date:  2018-04-01       Impact factor: 5.958

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.